We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RWAY:NASDAQRunway Growth Finance Corp. Analysis

Data as of 2026-06-09 - not real-time

$6.01

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Runway Growth Finance Corp. is trading near a key support level with the short‑term moving average below the mid‑term moving average, confirming a bearish technical stance. The relative strength index sits in the lower region, hinting at oversold conditions, while the MACD line remains beneath its signal line, reinforcing the downside bias. Price action reflects a substantial discount to its historical premium, and the price‑to‑earnings multiple is far below the industry average, suggesting the stock may be undervalued. However, the dividend yield is exceptionally high yet the payout ratio exceeds earnings, raising questions about dividend sustainability. The balance sheet shows a high debt load relative to equity, adding leverage risk, while beta is below one, indicating limited market sensitivity. Volatility is elevated, and trading volume has been on a downward trend, pointing to liquidity concerns.
Despite the bearish technical backdrop, the forward earnings outlook is positive, and the company’s focus on senior‑secured loans to growth‑oriented sectors provides exposure to attractive industry tailwinds. The discount to net asset value, combined with a low valuation multiple, could offer upside if the market re‑prices the risk. Investors should weigh the high dividend yield against the sustainability concerns and consider the leverage and volatility when forming a view on the stock.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near support
  • bearish technical indicators
  • elevated volatility

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • significant discount to net asset value
  • low valuation multiples
  • high dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • potential earnings improvement
  • positive forward earnings outlook
  • exposure to growth‑focused sectors

Key Metrics & Analysis

Financial Health

Revenue Growth-16.80%
Profit Margin-2.00%
P/E Ratio4.6
ROE-0.56%
ROA6.12%
Debt/Equity100.79
P/B Ratio0.5
Op. Cash Flow$118.7M
Free Cash Flow$20.6M
Industry P/E16.9

Technical Analysis

TrendBearish
RSI34.2
Support$6.00
Resistance$6.71
MA 20$6.42
MA 50$6.58
MA 200$8.58
MACDBearish
VolumeDecreasing
Fear & Greed Index87.64

Valuation

Target Price$8.54
Upside/Downside42.12%
GradeUndervalued
TypeValue
Dividend Yield21.92%

Risk Assessment

Beta0.69
Volatility34.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.